Terms: = Lymphoma AND MALT1, ENSG00000172175, 10892
593 results:
1. Blood malt1 expression could help predict treatment outcomes in psoriasis patients, especially in those receiving biologics.
Liu Q; Zhang Y; Xu B; Jin X; Yang T; Fan L
Immun Inflamm Dis; 2024 Apr; 12(4):e1235. PubMed ID: 38578002
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of the malt1-LPCAT3 axis protects cartilage degeneration and osteoarthritis.
Kondreddy V; Banerjee R; Devi BLAP; Muralidharan K; Piramanayagam S
Cell Commun Signal; 2024 Mar; 22(1):189. PubMed ID: 38519981
[TBL] [Abstract] [Full Text] [Related]
3. Long-term monitoring of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the malt1 gene.
Iwamuro M; Takenaka R; Miyahara K; Okanoue S; Yoshioka M; Sakaguchi C; Yamamoto K; Kawai Y; Toyokawa T; Tanaka T; Otsuka M
Sci Rep; 2024 Feb; 14(1):4953. PubMed ID: 38418651
[TBL] [Abstract] [Full Text] [Related]
4. Development of Potent malt1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-
Liang X; Yu H; Liang R; Feng Z; Saidahmatov A; Sun C; Ren H; Wei X; Zhao J; Yang C; Liu H
J Med Chem; 2024 Feb; 67(4):2884-2906. PubMed ID: 38349664
[TBL] [Abstract] [Full Text] [Related]
5. Naturally occurring T cell mutations enhance engineered T cell therapies.
Garcia J; Daniels J; Lee Y; Zhu I; Cheng K; Liu Q; Goodman D; Burnett C; Law C; Thienpont C; Alavi J; Azimi C; Montgomery G; Roybal KT; Choi J
Nature; 2024 Feb; 626(7999):626-634. PubMed ID: 38326614
[TBL] [Abstract] [Full Text] [Related]
6. FPFT-2216, a Novel Anti-lymphoma Compound, Induces Simultaneous Degradation of IKZF1/3 and CK1α to Activate p53 and Inhibit NFκB Signaling.
Kanaoka D; Yamada M; Yokoyama H; Nishino S; Kunimura N; Satoyoshi H; Wakabayashi S; Urabe K; Ishii T; Nakanishi M
Cancer Res Commun; 2024 Feb; 4(2):312-327. PubMed ID: 38265263
[TBL] [Abstract] [Full Text] [Related]
7. The paracaspase malt1 controls cholesterol homeostasis in glioblastoma stem-like cells through lysosome proteome shaping.
Maghe C; Trillet K; André-Grégoire G; Kerhervé M; Merlet L; Jacobs KA; Schauer K; Bidère N; Gavard J
Cell Rep; 2024 Jan; 43(1):113631. PubMed ID: 38183651
[TBL] [Abstract] [Full Text] [Related]
8. In silico study of polyphenols as potential inhibitors of malt1 protein in non-Hodgkin lymphoma.
Sezer A; Mahmutović L; Akçeşme B
Med Oncol; 2023 Dec; 41(1):37. PubMed ID: 38155268
[TBL] [Abstract] [Full Text] [Related]
9. Identification of an Ortholog of malt1 from Shrimp That Induces NF-κB-Mediated Antiviral Immunity.
Wang H; Xiao B; Chen S; He J; Li C
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140602
[TBL] [Abstract] [Full Text] [Related]
10. Identification of Tensin-3 as a malt1 substrate that controls B cell adhesion and lymphoma dissemination.
Juilland M; Alouche N; Ubezzi I; Gonzalez M; Rashid HO; Scarpellino L; Erdmann T; Grau M; Lenz G; Luther SA; Thome M
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2301155120. PubMed ID: 38109544
[TBL] [Abstract] [Full Text] [Related]
11. Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family.
Staal J; Driege Y; Van Gaever F; Steels J; Beyaert R
FEBS J; 2024 Mar; 291(6):1220-1245. PubMed ID: 38098267
[TBL] [Abstract] [Full Text] [Related]
12. Primary central nervous system marginal zone lymphoma.
Flospergher E; Marino F; Calimeri T; Cangi MG; Ferreri AJM; Ponzoni M; Bongiovanni L
Br J Haematol; 2024 Jan; 204(1):31-44. PubMed ID: 38054330
[TBL] [Abstract] [Full Text] [Related]
13. Novel identification of t(14;18)(q32;q21)/IGH::malt1 in chronic lymphocytic leukaemia.
Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
[TBL] [Abstract] [Full Text] [Related]
14. Regulatory roles of CARD9-BCL10-Rac1 (CBR) signalome in islet β-cell function in health and metabolic stress: Is there room for malt1?
Kowluru A
Biochem Pharmacol; 2023 Dec; 218():115889. PubMed ID: 37991197
[TBL] [Abstract] [Full Text] [Related]
15. Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach.
VanDyke D; Xu L; Sargunas PR; Gilbreth RN; Baca M; Gao C; Hunt J; Spangler JB
J Biol Chem; 2023 Dec; 299(12):105381. PubMed ID: 37866632
[TBL] [Abstract] [Full Text] [Related]
16. malt1 Positively Relates to T Helper 1 and T Helper 17 cells, and Serves as a Potential Biomarker for Predicting 30-Day Mortality in Stanford Type A Aortic Dissection Patients.
Zong J; Yang L; Wei L; Wang D; Wang X; Zhang Z
Tohoku J Exp Med; 2023 Dec; 261(4):299-307. PubMed ID: 37704417
[TBL] [Abstract] [Full Text] [Related]
17. Linkage of Blood malt1 with CD4+ T Cell Subset, Inflammation, Lipid, and Its Potency as a Biomarker for Predicting Major Adverse Cardiovascular Events in Coronary Heart Disease Patients.
Zhang L; Li J; Yang Z; Wang S; Liu J; Luan S; Tian G
Ann Clin Lab Sci; 2023 Jul; 53(4):507-515. PubMed ID: 37625844
[TBL] [Abstract] [Full Text] [Related]
18. Oncogene-induced malt1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
[TBL] [Abstract] [Full Text] [Related]
19. Chemical Probes for Profiling of malt1 Protease Activity.
Verhelst SHL; Prothiwa M
Chembiochem; 2023 Nov; 24(21):e202300444. PubMed ID: 37607867
[TBL] [Abstract] [Full Text] [Related]
20. CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Decombis S; Bellanger C; Le Bris Y; Madiot C; Jardine J; Santos JC; Boulet D; Dousset C; Menard A; Kervoelen C; Douillard E; Moreau P; Minvielle S; Moreau-Aubry A; Tessoulin B; Roue G; Bidère N; Le Gouill S; Pellat-Deceunynck C; Chiron D
Blood; 2023 Nov; 142(18):1543-1555. PubMed ID: 37562004
[TBL] [Abstract] [Full Text] [Related]
[Next]
